Onconova Therapeutics, Inc. (ONTX) Files An 8-K Results of Operations and Financial Condition
Item2.02. Results of Operations and Financial Condition
On November14, 2016, Onconova Therapeutics,Inc. (the Company)
issued a press release announcing its financial results for the
quarter and nine months ended September30, 2016, a copy of which
is attached hereto as Exhibit99.1 and incorporated herein by
reference. The information contained in this Form8-K (including
the exhibit hereto) shall not be deemed filed for purposes of
Section18 of the Securities Exchange Act of 1934, as amended (the
Exchange Act), or incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act,
except as shall be expressly set forth by specific reference in
such a filing.
Item9.01. Financial Statements and Exhibits
(d)Exhibits.
|
99.1 |
Press release issued by the Company dated November14, 2016. |
About Onconova Therapeutics, Inc. (ONTX)
